U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. Liang Xu
  1. Science & Research (NCTR)

Liang Xu Ph.D.

Staff Fellow — Division of Bioinformatics and Biostatistics

No Photo Available


Liang Xu, Ph.D.
(870) 543-7121
NCTRResearch@fda.hhs.gov  

Back to NCTR Principal Investigators page


About  |  Publications


Background

Dr. Liang Xu received a Ph.D. in biomedical engineering from Dalian University of Technology in China, where he previously worked as a lecturer. He conducted postdoctoral research at the University of Texas at San Antonio and the University of Limerick in Ireland. Dr. Xu worked as a special volunteer at the National Cancer Institute at Frederick and a lab researcher at the University of Illinois Urbana-Champaign. Dr. Xu joined FDA’s National Center for Toxicological Research (NCTR) in 2022, as a staff fellow in the Division of Bioinformatics and Biostatistics.

Research Interests

Dr. Xu’s research focuses on the application of computational chemistry methods in the structure-function relationship of disease-related proteins. He has applied computational modeling and simulations to characterize the conformational dynamics of intrinsically disordered proteins associated with many neurodegenerative diseases. Dr. Xu is currently working on SARS-Cov-2-related proteins with computational biophysical approaches.

Selected Publications

Structural Insights into the Human Mitochondrial Pyruvate Carrier Complexes.
Xu L., Phelix C.F., and Chen L.Y.
J Chem Inf Model. 2021, 61(11):5614-5625.

Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter.
Xu L. and Chen L.Y.
J Chem Inf Model. 2020, 60(8):3958-3968.

Molecular Simulations Reveal Terminal Group Mediated Stabilization of Helical Conformers in Both Amyloid-β42 and α-Synuclein.
Bhattacharya S., Xu L., and Thompson D.
ACS Chem Neurosci. 2019, 10(6):2830-2842.

Re-Designing the α-Synuclein Tetramer.
Xu L., Bhattacharya S., and Thompson D.
Chem Commun (Camb). 2018, 54(58):8080-8083.

Familial Mutations May Switch Conformational Preferences in α-Synuclein Fibrils.
Xu L., Ma B., Nussinov R., and Thompson D.
ACS Chem Neurosci. 2017, 8(4):837-849.

Allosteric Stabilization of the Amyloid-β Peptide Hairpin by the Fluctuating N-Terminal.
Xu L., Nussinov R., and Ma B.
Chem Commun (Camb). 2016, 52(8):1733-6.

Coupling of the Non-Amyloid-Component (NAC) Domain and the KTK(E/Q)GV Repeats Stabilize the α-Synuclein Fibrils.
Xu L., Nussinov R., and Ma B.
Eur J Med Chem. 2016, 121:841-850.


Contact Information
Liang Xu
(870) 543-7121
Expertise
Expertise
Approach
Domain
Technology & Discipline
Toxicology
Back to Top